References

10.1053/j.gastro.2024.01.049

10.1053/j.gastro.2024.01.049 · External reference

10.1136/gutjnl-2020-322362

10.1136/gutjnl-2020-322362 · External reference

Priming and Maintenance of Adaptive Immunity in the Liver

10.1146/annurev-immunol-090122-041354 · 2024 · External reference

The history and promise of Treg cells

10.1016/j.immuni.2025.11.011 · 2025 · External reference

Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis

10.1016/j.jhep.2020.06.044 · 2021 · External reference

5-Aza-2-deoxycytidine alleviates the progression of primary biliary cholangitis by suppressing the FoxP3 methylation and promoting the Treg/Th17 balance

10.1016/j.intimp.2021.107820 · 2021 · External reference

10.1016/j.jhep.2021.03.016

10.1016/j.jhep.2021.03.016 · External reference

10.1002/hep.31739

10.1002/hep.31739 · External reference

10.1155/2020/3019378

10.1155/2020/3019378 · External reference

Conventional type 1 dendritic cells are essential for the development of primary biliary cholangitis

10.1111/liv.15961 · 2024 · External reference

10.1016/j.jhep.2018.05.018

10.1016/j.jhep.2018.05.018 · External reference

10.1136/gutjnl-2025-337652

10.1136/gutjnl-2025-337652 · External reference

10.1038/s41423-019-0199-z

10.1038/s41423-019-0199-z · External reference

Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis

10.3389/fimmu.2019.01065 · 2019 · External reference

10.1002/hep.29782

10.1002/hep.29782 · External reference

10.1038/s41423-020-00592-6

10.1038/s41423-020-00592-6 · External reference

10.1038/s41579-023-00904-3

10.1038/s41579-023-00904-3 · External reference

Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling

10.1038/s42255-021-00452-1 · 2021 · External reference

10.1136/gutjnl-2018-317836

10.1136/gutjnl-2018-317836 · External reference

10.1136/gutjnl-2016-313332

10.1136/gutjnl-2016-313332 · External reference

10.1136/gutjnl-2015-310500

10.1136/gutjnl-2015-310500 · External reference

10.1038/s41575-022-00690-y

10.1038/s41575-022-00690-y · External reference

10.1053/j.gastro.2020.12.058

10.1053/j.gastro.2020.12.058 · External reference

10.1136/gutjnl-2018-317791

10.1136/gutjnl-2018-317791 · External reference

10.1136/gutjnl-2020-323565

10.1136/gutjnl-2020-323565 · External reference

Characteristics of regulatory T-cell function in patients with chronic hepatitis B and C coinfection

10.1111/jvh.13298 · 2020 · External reference

10.1016/j.jhep.2021.07.032

10.1016/j.jhep.2021.07.032 · External reference

10.1016/j.jhep.2021.08.029

10.1016/j.jhep.2021.08.029 · External reference

10.1002/hep.23792

10.1002/hep.23792 · External reference

10.1016/j.jhep.2012.02.029

10.1016/j.jhep.2012.02.029 · External reference

Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment

10.1002/hep4.1202 · 2018 · External reference

10.1016/j.jhep.2014.05.034

10.1016/j.jhep.2014.05.034 · External reference

Expanded but dysfunctional regulatory T cells in treatment-naïve autoimmune hepatitis

10.1007/s12072-025-10986-1 · 2026 · External reference

Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis

10.1038/s41419-017-0010-y · 2017 · External reference

10.4049/jimmunol.1502276

10.4049/jimmunol.1502276 · External reference

Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis

10.1002/hep.29307 · 2017 · External reference

Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis

10.1016/j.clim.2017.12.004 · 2018 · External reference

Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis

10.1016/j.jhepr.2025.101678 · 2026 · External reference

Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis

10.1016/j.jceh.2020.04.014 · 2020 · External reference

HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction

10.4049/jimmunol.2100186 · 2023 · External reference

Inflammasome Priming Mediated via Toll-Like Receptors 2 and 4, Induces Th1-Like Regulatory T Cells in De Novo Autoimmune Hepatitis

10.3389/fimmu.2018.01612 · 2018 · External reference

An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis

10.1093/cei/uxag013 · 2026 · External reference

Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression

10.1097/hep.0000000000001419 · 2026 · External reference

Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis

10.3389/fphar.2021.726128 · 2021 · External reference

Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in mice

10.1002/hep.29812 · 2018 · External reference

Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway

10.3389/fimmu.2022.851560 · 2022 · External reference

10.1182/blood-2008-03-144980

10.1182/blood-2008-03-144980 · External reference

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver

10.1172/jci.insight.141462 · 2021 · External reference

Bifidobacterium mitigates autoimmune hepatitis by regulating IL-33-induced Treg/Th17 imbalance via the TLR2/4 signaling pathway

2024 · External reference

Berberine alleviates concanavalin A-induced autoimmune hepatitis in mice by modulating the gut microbiota

10.1097/hc9.0000000000000381 · 2024 · External reference

Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora

10.3389/fimmu.2024.1488125 · 2024 · External reference

Ethyl acetate extract from Herpetospermun cardigerum wall. Ameliorated concanavalin A-induced autoimmune hepatitis in mice by reprofiling gut microenvironment to modulate IDO1/KYN and PI3K/AKT/NF-κB pathways

10.1016/j.jep.2025.119578 · 2025 · External reference

10.1002/hep.21123

10.1002/hep.21123 · External reference

10.1016/j.jaut.2006.04.005

10.1016/j.jaut.2006.04.005 · External reference

10.1002/hep.22651

10.1002/hep.22651 · External reference

10.1136/jcp.2006.044776

10.1136/jcp.2006.044776 · External reference

10.1056/nejmoa0810440

10.1056/nejmoa0810440 · External reference

Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells

10.1016/j.jaut.2018.07.020 · 2018 · External reference

Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis

10.18632/oncotarget.22658 · 2017 · External reference

BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis

10.1590/1414-431x20132665 · 2013 · External reference

Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis

10.1080/08916930701619730 · 2008 · External reference

10.1002/hep.21385

10.1002/hep.21385 · External reference

10.4049/jimmunol.177.3.1655

10.4049/jimmunol.177.3.1655 · External reference

10.1053/j.gastro.2008.02.020

10.1053/j.gastro.2008.02.020 · External reference

10.1016/j.jaut.2015.01.011

10.1016/j.jaut.2015.01.011 · External reference

The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models

10.1186/s12876-024-03176-0 · 2024 · External reference

Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study

10.1097/md.0000000000038626 · 2024 · External reference

10.1016/j.jhep.2013.12.027

10.1016/j.jhep.2013.12.027 · External reference

STAT activation in regulatory CD4+ T cells of patients with primary sclerosing cholangitis

10.1002/iid3.1248 · 2024 · External reference

Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis

10.1016/j.celrep.2025.116557 · 2025 · External reference

10.1038/s41591-023-02372-x

10.1038/s41591-023-02372-x · External reference

10.1007/s10875-012-9801-1

10.1007/s10875-012-9801-1 · External reference

10.1136/gutjnl-2022-327075

10.1136/gutjnl-2022-327075 · External reference

10.4049/jimmunol.1800711

10.4049/jimmunol.1800711 · External reference

10.1038/nature12726

10.1038/nature12726 · External reference

10.1016/j.jhep.2016.12.001

10.1016/j.jhep.2016.12.001 · External reference

Bile acids engage the SIPR-STAT3 signaling axis to modulate regulatory T cell responses in fibrosing cholangiopathies

10.1016/j.jhep.2025.05.032 · 2025 · External reference

10.1002/hep.21697

10.1002/hep.21697 · External reference

Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases

10.1007/s00535-010-0199-3 · 2010 · External reference

Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis

10.1016/j.jhep.2013.06.016 · 2013 · External reference

10.1136/gut.2009.200972

10.1136/gut.2009.200972 · External reference

Targeting TGF-β signal transduction for fibrosis and cancer therapy

10.1186/s12943-022-01569-x · 2022 · External reference

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

10.1016/s2213-8587(13)70113-x · 2013 · External reference

10.1016/j.kint.2016.09.022

10.1016/j.kint.2016.09.022 · External reference

An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice

10.1126/sciimmunol.aba5264 · 2020 · External reference

10.1093/ecco-jcc/jjv144

10.1093/ecco-jcc/jjv144 · External reference

sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis

10.1186/s13287-023-03550-x · 2023 · External reference

A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials

10.1016/j.omtm.2018.01.006 · 2018 · External reference

10.1016/j.tibtech.2019.12.009

10.1016/j.tibtech.2019.12.009 · External reference

10.1182/blood-2016-07-727834

10.1182/blood-2016-07-727834 · External reference

Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis

10.1016/j.jaut.2021.102629 · 2021 · External reference

Changes in peripheral blood 25 - hydroxyvitamin D3, Th17 cells, and CD4+ regulatory T cells and their clinical significance in patients with primary biliary cirrhosis

2016 · External reference

10.1136/gutjnl-2024-333297

10.1136/gutjnl-2024-333297 · External reference

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

10.1016/j.jaut.2020.102591 · 2021 · External reference

Regulatory T cells in inflamed liver are dysfunctional in murine primary biliary cholangitis

10.1093/cei/uxad117 · 2024 · External reference

Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis

10.1002/hep.30061 · 2018 · External reference

10.1136/annrheumdis-2018-214229

10.1136/annrheumdis-2018-214229 · External reference

Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis

10.1002/hep.30059 · 2018 · External reference

Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases

10.1016/j.jhep.2025.06.007 · 2025 · External reference

10.4049/jimmunol.0901216

10.4049/jimmunol.0901216 · External reference

Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy

10.1016/j.jaut.2024.103327 · 2024 · External reference

10.1002/hep.24039

10.1002/hep.24039 · External reference

10.1002/hep.26023

10.1002/hep.26023 · External reference

Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis

10.1016/j.jhepr.2019.08.001 · 2019 · External reference

Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with UDCA-Resistant Primary Biliary Cirrhosis

10.1089/scd.2013.0500 · 2014 · External reference

Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells

10.1097/hc9.0000000000000110 · 2023 · External reference

10.1053/j.gastro.2012.02.041

10.1053/j.gastro.2012.02.041 · External reference

Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2

10.1016/j.jaut.2014.02.001 · 2014 · External reference

10.1038/nature07674

10.1038/nature07674 · External reference

10.1053/j.gastro.2010.05.075

10.1053/j.gastro.2010.05.075 · External reference

CD4+CD25+ but not CD4+Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis

10.1038/cmi.2010.40 · 2010 · External reference

10.1002/hep.22226

10.1002/hep.22226 · External reference